Other Titles

Direct Oral Anticoagulant Management in Patients Undergoing Cardiac Implantable Electronic Device Procedures [Symposium]

Abstract

Does direct oral anticoagulant (DOAC) management in the periprocedural period surrounding cardiac implantable electronic device (CIED) procedures have an impact on bleeding and thrombotic complication rates? We have analyzed complication rates and evaluated for any statistically significant contributing factors.

Notes

One combined slide deck was submitted for multiple presentations in this symposium. This slide deck will be attached to at least one other record in the repository. Please look for your preferred session within the combined presentation slides. To locate all records utilizing this slide deck, search by Alternative Title.

Author Details

Michelle L. Alland, MSN - Department of Cardiology, Mayo Clinic, Scottsdale, Arizona, USA

Sigma Membership

Non-member

Lead Author Affiliation

Mayo Clinic, Scottsdale, Arizona, USA

Type

Presentation

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Cardiac Implantable Electronic Device (CIED), Cardiology, Direct Oral Anticoagulant (DOAC)

Conference Name

28th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Dublin, Ireland

Conference Year

2017

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (2385 kB)

Share

COinS
 

Complication rates associated with direct oral anticoagulants in patients undergoing cardiac implantable electronic device procedures

Dublin, Ireland

Does direct oral anticoagulant (DOAC) management in the periprocedural period surrounding cardiac implantable electronic device (CIED) procedures have an impact on bleeding and thrombotic complication rates? We have analyzed complication rates and evaluated for any statistically significant contributing factors.